The first quarter of 2012 will soon be over. The Asian private equity industry seems to be humming along at a steady pace, although there hasn’t been anything particularly dramatic so far. Deal-making has been efficient and routine rather than startling, and (with the possible exception of Axiom Asia) we have yet to see anything particularly exciting on the fundraising side. The latter state of affairs may change in the second quarter.
All things said and done, the global economy may be bumpy and the private equity industry continues to be persecuted in the US, but optimism is in the air. Currently, there is no market in Asia that...
Bertelsmann India Investments has earmarked USD 500m, provided by its eponymous German parent, for investment in local start-ups. The VC unit’s total deployment since its launch in 2013 is USD 285m.
UK-headquartered incubator Entrepreneur First (EF) has raised USD 158m, targeted in part at investment in Southeast Asian start-ups and expanding its reach in the region.
CDH Investments has agreed to sell New Zealand-based supplements manufacturer The Better Health Company (TBHC) to Nestlé Health Science for an undisclosed sum.
India and Southeast Asia-focused Panthera Growth Partners has reached a first close on its second fund with commitments amounting to more than half the overall target of USD 250m.